Mineralys Therapeutics (MLYS) Earnings Date, Estimates & Call Transcripts $39.81 +1.89 (+4.98%) Closing price 04:00 PM EasternExtended Trading$41.05 +1.24 (+3.11%) As of 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mineralys Therapeutics Earnings Summary Mineralys Therapeutics posted Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.66, which topped analysts' consensus estimates of -$0.78 by $0.12. With a trailing EPS of -$3.56, Mineralys Therapeutics' earnings are expected to decrease next year, from ($4.23) to ($4.48) per share. Upcoming Q3 Earnings DateNov. 10After Market ClosesEstimatedConsensus EPS (Aug. 12) -$0.78 Actual EPS (Aug. 12) -$0.66 Beat By $0.12 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingMLYS Upcoming EarningsMineralys Therapeutics' next earnings date is estimated for Monday, November 10, 2025, based on past reporting schedules. Powered by Get Mineralys Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mineralys Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataMLYS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Mineralys Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.90-$0.90-$0.90Q2 20252-$0.85-$0.81-$0.83Q3 20252-$0.74-$0.69-$0.72Q4 20252-$0.82-$0.71-$0.77 Mineralys Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/10/2025(Estimated)--------8/12/2025Q2 2025-$0.78-$0.66+$0.12-$0.66--5/12/2025Q1 2025-$1.02-$0.79+$0.23-$0.79--2/12/2025Q4 2024-$1.00-$0.98+$0.02-$0.98--11/11/2024Q3 2024-$0.83-$1.13 -$0.30-$1.13--8/13/2024Q2 2024-$0.73-$0.83 -$0.10-$0.83--5/9/2024Q1 2024-$0.68-$0.70 -$0.02-$0.70--3/21/2024Q4 2023-$0.85-$0.61+$0.24-$0.61--11/7/2023Q3 2023-$0.72-$0.57+$0.15-$0.57-- Mineralys Therapeutics Earnings - Frequently Asked Questions When is Mineralys Therapeutics' earnings date? Mineralys Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 10th, 2025 based off last year's report dates. Learn more on MLYS's earnings history. Did Mineralys Therapeutics beat their earnings estimates last quarter? In the previous quarter, Mineralys Therapeutics (NASDAQ:MLYS) reported ($0.66) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.78) by $0.12. Learn more on analysts' earnings estimate vs. MLYS's actual earnings. How can I listen to Mineralys Therapeutics' earnings conference call? The conference call for Mineralys Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Mineralys Therapeutics' conference call transcript? The conference call transcript for Mineralys Therapeutics' latest earnings report can be read online. Read Transcript How can I view Mineralys Therapeutics' earnings report? Mineralys Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much profit does Mineralys Therapeutics generate each year? Mineralys Therapeutics (NASDAQ:MLYS) has a recorded net income of -$177.81 million. MLYS has generated -$3.56 earnings per share over the last four quarters. What is Mineralys Therapeutics' EPS forecast for next year? Mineralys Therapeutics' earnings are expected to decrease from ($4.23) per share to ($4.48) per share in the next year. More Earnings Resources from MarketBeat Related Companies ROIV Earnings Date QGEN Earnings Date ELAN Earnings Date BBIO Earnings Date MRNA Earnings Date VRNA Earnings Date RVMD Earnings Date RYTM Earnings Date RNA Earnings Date ABVX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings This page (NASDAQ:MLYS) was last updated on 10/1/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredTrump is Fast-Tracking These Three CompaniesThe Trump administration is planning to invest DIRECTLY in a small sector of the stock market… And they just r...InvestorPlace | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
